F L Stassen

1.1k total citations
49 papers, 938 citations indexed

About

F L Stassen is a scholar working on Social Psychology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, F L Stassen has authored 49 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Social Psychology, 27 papers in Pulmonary and Respiratory Medicine and 16 papers in Molecular Biology. Recurrent topics in F L Stassen's work include Neuroendocrine regulation and behavior (30 papers), Electrolyte and hormonal disorders (21 papers) and Neonatal Respiratory Health Research (9 papers). F L Stassen is often cited by papers focused on Neuroendocrine regulation and behavior (30 papers), Electrolyte and hormonal disorders (21 papers) and Neonatal Respiratory Health Research (9 papers). F L Stassen collaborates with scholars based in United States, United Kingdom and Netherlands. F L Stassen's co-authors include Stanley T. Crooke, George J. Cardinale, William F. Huffman, Sidney Udenfriend, Lewis B. Kinter, P Nambi, Nambi Aiyar, Lisa R. Grillone, RW Godfrey and M A Clark and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

F L Stassen

49 papers receiving 874 citations

Peers

F L Stassen
Deborah Trinder Australia
Zhiyu Yang Australia
J Tayot France
Matthew S. Stratton United States
Benjamin C. Yaden United States
F L Stassen
Citations per year, relative to F L Stassen F L Stassen (= 1×) peers Maria A. Burnatowska-Hledin

Countries citing papers authored by F L Stassen

Since Specialization
Citations

This map shows the geographic impact of F L Stassen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F L Stassen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F L Stassen more than expected).

Fields of papers citing papers by F L Stassen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F L Stassen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F L Stassen. The network helps show where F L Stassen may publish in the future.

Co-authorship network of co-authors of F L Stassen

This figure shows the co-authorship network connecting the top 25 collaborators of F L Stassen. A scholar is included among the top collaborators of F L Stassen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F L Stassen. F L Stassen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Albrightson-Winslow, C R, B Brickson, David P. Brooks, et al.. (1990). Vasopressin antidiuretic agonist and antagonist activity in dogs: structural and stereochemical relationship between bridge and carboxyl terminus.. Journal of Pharmacology and Experimental Therapeutics. 256(1). 335–340. 3 indexed citations
2.
Brooks, David P., Paul F. Koster, Christine R. Albrightson, et al.. (1989). Vasopressin receptor antagonism in rhesus monkey and man: stereochemical requirements. European Journal of Pharmacology. 160(1). 159–162. 7 indexed citations
3.
Aiyar, Nambi, et al.. (1989). Solubilization of a guanine nucleotide-sensitive form of vasopressin V2 receptors from porcine kidney. Archives of Biochemistry and Biophysics. 268(2). 698–706. 13 indexed citations
4.
Albrightson-Winslow, C R, et al.. (1989). Cyclooxygenase inhibition unmasks the full antidiuretic agonist activity of the vasopressin antagonist, SK&F 101926, in dogs.. Journal of Pharmacology and Experimental Therapeutics. 249(2). 366–371. 5 indexed citations
5.
Brooks, David P., Paul F. Koster, C R Albrightson-Winslow, et al.. (1988). SK&F 105494 is a potent antidiuretic hormone antagonist in the rhesus monkey (Macaca mulatta).. PubMed. 245(1). 211–5. 16 indexed citations
6.
Hempel, Judith C., William F. Huffman, Garland R. Marshall, et al.. (1988). Design, synthesis, and biological activity of a peptide mimic of vasopressin. Journal of Medicinal Chemistry. 31(4). 742–744. 2 indexed citations
7.
Brooks, David P., Paul F. Koster, F L Stassen, et al.. (1988). Flushing and haemodynamic responses to vasopressin peptides in the rhesus monkey. British Journal of Pharmacology. 94(3). 759–764. 7 indexed citations
8.
Crooke, Stanley T., Ponnal Nambi, Nambi Aiyar, F L Stassen, & Lisa R. Grillone. (1988). Vasopressin V1 receptors and inter-receptor regulation in vascular smooth muscle cells. Biochemical Pharmacology. 37(11). 2105–2108. 6 indexed citations
9.
Kinter, Lewis B., William F. Huffman, & F L Stassen. (1988). Antagonists of the antidiuretic activity of vasopressin. American Journal of Physiology-Renal Physiology. 254(2). F165–F177. 47 indexed citations
10.
Brickson, B, Lewis B. Kinter, David P. Brooks, et al.. (1988). SK&F 105494: a potent antidiuretic hormone antagonist devoid of partial agonist activity in dogs.. Journal of Pharmacology and Experimental Therapeutics. 247(3). 897–901. 2 indexed citations
11.
Brickson, B, Lewis B. Kinter, David P. Brooks, et al.. (1988). SK&F 105494: a potent antidiuretic hormone antagonist devoid of partial agonist activity in dogs.. PubMed. 247(3). 897–901. 7 indexed citations
12.
Aiyar, Nambi, P Nambi, F L Stassen, & Stanley T. Crooke. (1987). Solubilization and reconstitution of vasopressin V1 receptors of rat liver.. Molecular Pharmacology. 32(1). 34–36. 11 indexed citations
13.
Ali, Fadia E., William F. Huffman, Lewis B. Kinter, et al.. (1987). Potent vasopressin antagonist modified at the carboxy-terminal tripeptide tail. Journal of Medicinal Chemistry. 30(12). 2291–2294. 2 indexed citations
14.
Stassen, F L, et al.. (1987). Identification and characterization of vascular (V1) vasopressin receptors of an established smooth muscle cell line.. Molecular Pharmacology. 31(3). 259–266. 24 indexed citations
15.
Stassen, F L, Dulcie B. Schmidt, P Nambi, et al.. (1987). A novel radiolabeled vasopressin antagonist: [3H-Phe]-desGlyd(CH2)5D-Tyr(Et)VAVP, [3H]-SK&F 101926.. Molecular Pharmacology. 31(3). 267–272. 1 indexed citations
16.
Aiyar, Nambi, P Nambi, F L Stassen, & Stanley T. Crooke. (1987). Effects of N-ethylmaleimide on arginine vasopressin-induced responses in an established smooth muscle cell line.. Journal of Pharmacology and Experimental Therapeutics. 242(1). 217–221. 5 indexed citations
17.
Aiyar, N, et al.. (1987). Phorbol ester-mediated inhibition of vasopressin and beta-adrenergic responses in a vascular smooth muscle cell line.. Molecular Pharmacology. 31(2). 180–184. 47 indexed citations
19.
Kinter, Lewis B., Susanne Churchill, F L Stassen, M. Lane Moore, & William F. Huffman. (1987). Vasopressin antagonism in the squirrel monkey (Saimiri sciureus).. Journal of Pharmacology and Experimental Therapeutics. 241(3). 797–803. 10 indexed citations
20.
Stassen, F L, et al.. (1979). Complement-Mediated Solubilization of Immune Precipitates Prepared with Antibodies of Different Avidity. The Journal of Immunology. 123(2). 535–542. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026